336 related articles for article (PubMed ID: 17200202)
1. Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes.
Merritt TM; Bick R; Poindexter BJ; Alcorn JL; Hecht JT
Am J Pathol; 2007 Jan; 170(1):293-300. PubMed ID: 17200202
[TBL] [Abstract][Full Text] [Related]
2. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
3. COMP mutations, chondrocyte function and cartilage matrix.
Hecht JT; Hayes E; Haynes R; Cole WG
Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
[TBL] [Abstract][Full Text] [Related]
4. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
Merritt TM; Alcorn JL; Haynes R; Hecht JT
J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
[TBL] [Abstract][Full Text] [Related]
6. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia.
Vranka J; Mokashi A; Keene DR; Tufa S; Corson G; Sussman M; Horton WA; Maddox K; Sakai L; Bächinger HP
Matrix Biol; 2001 Nov; 20(7):439-50. PubMed ID: 11691584
[TBL] [Abstract][Full Text] [Related]
7. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia.
Maddox BK; Keene DR; Sakai LY; Charbonneau NL; Morris NP; Ridgway CC; Boswell BA; Sussman MD; Horton WA; Bächinger HP; Hecht JT
J Biol Chem; 1997 Dec; 272(49):30993-7. PubMed ID: 9388247
[TBL] [Abstract][Full Text] [Related]
8. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
[TBL] [Abstract][Full Text] [Related]
9. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH.
Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM
Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
[TBL] [Abstract][Full Text] [Related]
11. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes.
Chen TL; Posey KL; Hecht JT; Vertel BM
J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134
[TBL] [Abstract][Full Text] [Related]
12. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.
Suleman F; Gualeni B; Gregson HJ; Leighton MP; Piróg KA; Edwards S; Holden P; Boot-Handford RP; Briggs MD
Hum Mutat; 2012 Jan; 33(1):218-31. PubMed ID: 22006726
[TBL] [Abstract][Full Text] [Related]
13. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.
Piróg-Garcia KA; Meadows RS; Knowles L; Heinegård D; Thornton DJ; Kadler KE; Boot-Handford RP; Briggs MD
Hum Mol Genet; 2007 Sep; 16(17):2072-88. PubMed ID: 17588960
[TBL] [Abstract][Full Text] [Related]
14. Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.
Hashimoto Y; Tomiyama T; Yamano Y; Mori H
Am J Pathol; 2003 Jul; 163(1):101-10. PubMed ID: 12819015
[TBL] [Abstract][Full Text] [Related]
15. Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain.
Kleerekoper Q; Hecht JT; Putkey JA
J Biol Chem; 2002 Mar; 277(12):10581-9. PubMed ID: 11782471
[TBL] [Abstract][Full Text] [Related]
16. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX.
Thur J; Rosenberg K; Nitsche DP; Pihlajamaa T; Ala-Kokko L; Heinegård D; Paulsson M; Maurer P
J Biol Chem; 2001 Mar; 276(9):6083-92. PubMed ID: 11084047
[TBL] [Abstract][Full Text] [Related]
17. An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.
Posey KL; Veerisetty AC; Liu P; Wang HR; Poindexter BJ; Bick R; Alcorn JL; Hecht JT
Am J Pathol; 2009 Oct; 175(4):1555-63. PubMed ID: 19762713
[TBL] [Abstract][Full Text] [Related]
18. Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP.
Weirich C; Keene DR; Kirsch K; Heil M; Neumann E; Dinser R
Matrix Biol; 2007 May; 26(4):314-23. PubMed ID: 17307347
[TBL] [Abstract][Full Text] [Related]
19. Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.
Alcorn JL; Merritt TM; Farach-Carson MC; Wang HH; Hecht JT
RNA; 2009 Apr; 15(4):686-95. PubMed ID: 19237461
[TBL] [Abstract][Full Text] [Related]
20. Model systems for studying skeletal dysplasias caused by TSP-5/COMP mutations.
Posey KL; Yang Y; Veerisetty AC; Sharan SK; Hecht JT
Cell Mol Life Sci; 2008 Mar; 65(5):687-99. PubMed ID: 18193163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
